MMP-9 regulates disulphide isomerase activity of TGM2 to enhance fusion glycoprotein-mediated syncytium formation of respiratory syncytial virus
Protein & Cell · 01.01.2026 · 17 (1) · 59-76
DOI: 10.1093/procel/pwaf063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein & Cell, online erschienen am 11.08.2025. Verfasst von Bao Xue und 15 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 9, Respiratory Syncytial Virus Infections, Giant Cells, GTP-Binding Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong province, National Natural Science Foundation of China, Pearl River Talent Recruitment Program.
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) exploits host proteases to enhance its replication efficiency; however, the precise mechanisms remain unclear. Through high-throughput screening, we identified four matrix metalloproteinase 9 (MMP-9) inhibitors (including JNJ0966 and doxycycline hyclate) that suppress RSV infection in vitro and in vivo. Mechanistic studies revealed a proteolytic cascade wherein MMP-9 cleaves transglutaminase 2 (TGM2) at the PVP375↓VR site, generating an N-terminal fragment (1–375) that activates its protein disulfide isomerase (PDI) activity. This TGM2-dependent PDI activity catalyzes disulfide bond rearrangement in the RSV fusion glycoprotein (F), enabling F protein maturation, a prerequisite for membrane fusion and syncytium formation—key processes driving late-stage viral propagation. Genetic ablation of MMP-9 significantly attenuated RSV infectivity, while pharmacological inhibition reduced pulmonary viral loads and mitigated lung pathology in infected mice. Our study defines a unified MMP-9→TGM2→F axis as the core mechanism driving RSV replication and validates MMP-9 as a therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.
- Guangzhou National Laboratory, Guangzhou 510005, China.
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
- State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou 511436, China.
- Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
ORCID-Profile: Qi Yang, Xinwen Chen
Förderung
- Natural Science Foundation of Guangdong province
- National Natural Science Foundation of China
- Pearl River Talent Recruitment Program
- Major Project of Guangzhou National Laboratory
- Basic and Applied Basic Research Projects of Guangzhou Basic Research Program
Zitieren
APA
Xue, B., Zhou, A., Zhong, Y., Mao, Y., Peng, R., Chen, Y., Zhong, J., Liu, J., Zhou, Y., Fang, Y., Zhang, W., Tang, J., Peng, W., Liu, J., Yang, Q., & Chen, X. (2026). MMP-9 regulates disulphide isomerase activity of TGM2 to enhance fusion glycoprotein-mediated syncytium formation of respiratory syncytial virus. Protein & Cell, 17(1), 59-76. https://doi.org/10.1093/procel/pwaf063
Vancouver
Xue B, Zhou A, Zhong Y, Mao Y, Peng R, Chen Y, et al. MMP-9 regulates disulphide isomerase activity of TGM2 to enhance fusion glycoprotein-mediated syncytium formation of respiratory syncytial virus. Protein & Cell. 2026;17(1):59-76. doi:10.1093/procel/pwaf063
BibTeX
@article{Xue2026,
author = {Xue, Bao and Zhou, Anqi and Zhong, Yihang and Mao, Yuhan and Peng, Ran and Chen, Yuhang and Zhong, Jiayi and Liu, Junjun and Zhou, Yuan and Fang, Yuying and Zhang, Wei and Tang, Jielin and Peng, Wei and Liu, Jia and Yang, Qi and Chen, Xinwen},
title = {MMP-9 regulates disulphide isomerase activity of TGM2 to enhance fusion glycoprotein-mediated syncytium formation of respiratory syncytial virus},
journal = {Protein & Cell},
year = {2026},
volume = {17},
number = {1},
pages = {59--76},
doi = {10.1093/procel/pwaf063}
}
EUVIMED